Novel breakthroughs in mobile health technology like Apple’s ResearchKit app development platform present a promising new path forward for pharmaceutical sponsors seeking more efficient trials, higher patient engagement, and deeper clinical insights. However, many clinical trials sponsors still seem to have doubts about regulators and their posture towards clinical study data that doesn’t come from using decades-old methods and practices.

from Forbes – Tech http://ift.tt/1Pl7gB1
via IFTTT